Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Aof Safety and Immunogenicity of Non-adjuvanted Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants, Produced by Butantan Institute

NCT01218685 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT01218685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Aof Safety and Immunogenicity of Non-adjuvanted Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants, Produced by Butantan Institute
Lead sponsor
Butantan Institute
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2011
Enrollment
1,152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunocompromised patients, immunogenicity of pandemic influenza a (h1n1)vaccine, safety of pandemic influenza a (h1n1)vaccine